A Biotech Unveils Its New Gene Control Technology – Barron’s
When she helped start MeiraGTx Holdings in 2015, CEO Zandy Forbes wanted to find a way to precisely control the output of genes implanted in people to fix genetic disorders. In an analyst meeting Wednesday, MeiraGTx unveiled that technology.
The small-cap developer of gene therapies presented data showing its ability to insert genes in lab animals that generate antibodies against cancer or Alzheimer-associated proteins, or crucial hormones like insulin. But the company’s modified genes only become active when MeiraGTx (ticker:…
Source: https://www.barrons.com/articles/a-biotech-unveils-its-new-gene-control-technology-51639687773